Stock OVID OVID THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-09 pm EDT 		5-day change 1st Jan Change
0.8299 USD -0.71% Intraday chart for Ovid Therapeutics Inc. +7.31% -74.23%
Jul. 09 Immunic Names President/COO, Chief Development Officer MT
Jul. 09 Immunic Names Jason Tardio as COO, Werner Gladdines as Chief Development Officer MT

MarketScreener Strategies

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OVID Stock
  4. News Ovid Therapeutics Inc.
  5. MarketScreener Strategies